Urology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Chapple C et al. – Men with bothersome OAB symptoms despite continued alpha–blocker therapy showed significantly greater improvements in diary variables, IPSS Storage scores, and symptom bother when receiving additional tolterodine ER versus placebo plus alpha–blocker.

Related Articles

Fesoterodine for the Treatment of Overactive Bladder
Annals of Pharmacotherapy, 11/18/09    Relevance Score: 69%

The importance of bladder wall thickness in the assessment of overactive bladder
Current Bladder Dysfunction Reports, 11/13/09    Relevance Score: 69%

The relationship between sleep apnea and overactive bladder
Current Urology Reports, 11/17/09    Relevance Score: 68%

Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study
BJU International, 10/13/09    Relevance Score: 68%

Frequently asked questions in the evaluation and management of overactive bladder
The Journal of Family Practice, 11/02/09    Relevance Score: 67%

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address